BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 18297056)

  • 1. Engineered lentivector targeting of dendritic cells for in vivo immunization.
    Yang L; Yang H; Rideout K; Cho T; Joo KI; Ziegler L; Elliot A; Walls A; Yu D; Baltimore D; Wang P
    Nat Biotechnol; 2008 Mar; 26(3):326-34. PubMed ID: 18297056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virological and preclinical characterization of a dendritic cell targeting, integration-deficient lentiviral vector for cancer immunotherapy.
    Odegard JM; Kelley-Clarke B; Tareen SU; Campbell DJ; Flynn PA; Nicolai CJ; Slough MM; Vin CD; McGowan PJ; Nelson LT; Ter Meulen J; Dubensky TW; Robbins SH
    J Immunother; 2015; 38(2):41-53. PubMed ID: 25658613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity.
    He Y; Zhang J; Mi Z; Robbins P; Falo LD
    J Immunol; 2005 Mar; 174(6):3808-17. PubMed ID: 15749922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cell-directed vaccination with a lentivector encoding PSCA for prostate cancer in mice.
    Xiao L; Joo KI; Lim M; Wang P
    PLoS One; 2012; 7(11):e48866. PubMed ID: 23139820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redirecting lentiviral vectors pseudotyped with Sindbis virus-derived envelope proteins to DC-SIGN by modification of N-linked glycans of envelope proteins.
    Morizono K; Ku A; Xie Y; Harui A; Kung SK; Roth MD; Lee B; Chen IS
    J Virol; 2010 Jul; 84(14):6923-34. PubMed ID: 20484510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An engineered novel lentivector specifically transducing dendritic cells and eliciting robust HBV-specific CTL response by upregulating autophagy in T cells.
    Ma S; Chen X; Tan Q; Li D; Dai S; Wu S; Yu Y; Zang G; Tang Z
    Cell Cycle; 2018; 17(10):1220-1234. PubMed ID: 30019620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization of mice with lentiviral vectors targeted to MHC class II+ cells is due to preferential transduction of dendritic cells in vivo.
    Ciré S; Da Rocha S; Yao R; Fisson S; Buchholz CJ; Collins MK; Galy A
    PLoS One; 2014; 9(7):e101644. PubMed ID: 25058148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells.
    Okada N; Saito T; Masunaga Y; Tsukada Y; Nakagawa S; Mizuguchi H; Mori K; Okada Y; Fujita T; Hayakawa T; Mayumi T; Yamamoto A
    Cancer Res; 2001 Nov; 61(21):7913-9. PubMed ID: 11691812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonintegrating lentiviral vectors can effectively deliver ovalbumin antigen for induction of antitumor immunity.
    Hu B; Yang H; Dai B; Tai A; Wang P
    Hum Gene Ther; 2009 Dec; 20(12):1652-64. PubMed ID: 19663564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.
    Rowe HM; Lopes L; Ikeda Y; Bailey R; Barde I; Zenke M; Chain BM; Collins MK
    Mol Ther; 2006 Feb; 13(2):310-9. PubMed ID: 16275163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of effective therapeutic antitumor immunity by direct in vivo administration of lentiviral vectors.
    Dullaers M; Van Meirvenne S; Heirman C; Straetman L; Bonehill A; Aerts JL; Thielemans K; Breckpot K
    Gene Ther; 2006 Apr; 13(7):630-40. PubMed ID: 16355115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
    Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of vFLIP in a lentiviral vaccine vector activates NF-{kappa}B, matures dendritic cells, and increases CD8+ T-cell responses.
    Rowe HM; Lopes L; Brown N; Efklidou S; Smallie T; Karrar S; Kaye PM; Collins MK
    J Virol; 2009 Feb; 83(4):1555-62. PubMed ID: 19036811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response.
    Uhlig KM; Schülke S; Scheuplein VA; Malczyk AH; Reusch J; Kugelmann S; Muth A; Koch V; Hutzler S; Bodmer BS; Schambach A; Buchholz CJ; Waibler Z; Scheurer S; Mühlebach MD
    J Virol; 2015 Sep; 89(17):9044-60. PubMed ID: 26085166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo targeting of human DC-SIGN drastically enhances CD8⁺ T-cell-mediated protective immunity.
    Hesse C; Ginter W; Förg T; Mayer CT; Baru AM; Arnold-Schrauf C; Unger WW; Kalay H; van Kooyk Y; Berod L; Sparwasser T
    Eur J Immunol; 2013 Oct; 43(10):2543-53. PubMed ID: 23784881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cell-directed lentivector vaccine induces antigen-specific immune responses against murine melanoma.
    Yang HG; Hu BL; Xiao L; Wang P
    Cancer Gene Ther; 2011 May; 18(5):370-80. PubMed ID: 21372855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity.
    Shibagaki N; Udey MC
    J Immunol; 2002 Mar; 168(5):2393-401. PubMed ID: 11859130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with a lentivector that targets tumor antigen expression to dendritic cells induces potent CD8+ and CD4+ T-cell responses.
    Lopes L; Dewannieux M; Gileadi U; Bailey R; Ikeda Y; Whittaker C; Collin MP; Cerundolo V; Tomihari M; Ariizumi K; Collins MK
    J Virol; 2008 Jan; 82(1):86-95. PubMed ID: 17959670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent vaccine therapy with dendritic cells genetically modified by the gene-silencing-resistant retroviral vector GCDNsap.
    Nabekura T; Otsu M; Nagasawa T; Nakauchi H; Onodera M
    Mol Ther; 2006 Feb; 13(2):301-9. PubMed ID: 16311073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conventional dendritic cells are required for the activation of helper-dependent CD8 T cell responses to a model antigen after cutaneous vaccination with lentiviral vectors.
    Goold HD; Escors D; Conlan TJ; Chakraverty R; Bennett CL
    J Immunol; 2011 Apr; 186(8):4565-72. PubMed ID: 21389256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.